MedTrace Logo

Blastocystis and Cryptosporidium Infection in Colorectal Cancer Patients

NCT06379035 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2024-04-23

No results posted yet for this study

Summary

1. Detect the prevelance of Blastocystis spp. and Cryptosporidium spp. among patients with colorectal cancer attending South Egypt Cancer Institute-Assiut University.
2. Detect the effect of Blastocystis and Cryptosporidium infection on various cytokines level in CRC patients that may be involved in the tumor progression.

Conditions

Interventions

DIAGNOSTIC_TEST

ELISA / PCR

Multiplex PCR for confirmation of diagnosis of Blastocystis and Cryptosporidium infection. Enzyme linked immunosorbent assay (Elisa) for detection of : Different cytokines level in Colorectal cancer patients that may be involved in the tumor progression due to Blastocystis and Cryptosporidium infection.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Salma Mohammed Abd-ElRahman, Prof.Dr · Assiut University

  • Rasha Abd-ElMonem Hassan, Prof.Dr · Assiut University

  • Yasser Mohamed Mokhtar, Assis.Prof.Dr · Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-11-01
Completion
2025-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06379035 on ClinicalTrials.gov